Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : Biotech & Pharma.T.A, -- Ignore unavailable to you. Want to Upgrade?

To: Jibacoa who wrote (2163)	1/17/2008 11:08:59 AM
From: Jibacoa	Read Replies (1) \| Respond to of 3722

NGEN has been forming a base at the $0.30 level. The stock is up 6.25% on moderate volume of 40Ks, about 0.1 of its ADV bigcharts.marketwatch.com NGEN has 2Qs of triple digit & 2Qs of double digit improvement on revenues, & has been able to trim some its losses.<g> It trades around 0.4xBV, the short ratio came down 40% & is around 2x its ADV. If the stock could get to test its Oct11 H at $1.08 or just trade at $1, it would be a good % gain from present levels.<g> bigcharts.marketwatch.com Bernard